[ 161 Tb]Tb PSMA I&T

N/A

Report date: 2025/11/20 13:28:15
NME

Base Information

Drug Name[ 161 Tb]Tb PSMA I&T
Drug Alias Name[161Tb]Tb-PSMA-I&T
ClassificationRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeter Maccallum Cancer Centre, Australia
China Registration ClassN/A

Develop Information

Active CompaniesPeter Maccallum Cancer Centre, AustraliaAmerican Friends Of Rabin Medical Center Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A